One of the approaches that already showed efficacy toward Ph+ B-ALL primary cells in vitro was the inhibition of SHIP1 phosphatase using 3 α aminocholestane, causing hyperactivation of pre-BCR signaling [160]. Here, BCR is linked to acute lymphoblastic leukemia.